bf/NASDAQ:SRPT_icon.jpeg

NASDAQ:SRPT

Sarepta Therapeutics, Inc.

  • Stock

USD

Last Close

132.74

17/05 20:00

Market Cap

11.11B

Beta: 1.02

Volume Today

848.47K

Avg: 1.51M

PE Ratio

−16.13

PFCF: −19.07

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
3.63M
-
20.36M
461.59%
30.17M
48.20%
19.84M
34.23%
48.21M
142.95%
104.53M
116.82%
148.41M
41.99%
201.67M
35.89%
209.09M
3.68%
195.09M
6.69%
263.41M
35.02%
average payables
12.58M
-
15.02M
19.38%
16.32M
8.65%
24.96M
52.94%
19.08M
23.57%
21.15M
10.85%
50.96M
140.98%
89.59M
75.80%
93.92M
4.83%
86.31M
8.10%
130.40M
51.08%
average receivables
4.12M
-
2.97M
27.87%
3.20M
7.52%
4.60M
43.99%
17.35M
276.93%
39.26M
126.29%
71.49M
82.11%
116.26M
62.62%
155.11M
33.42%
215.67M
39.04%
330.01M
53.02%
book value per share
7.30
-
6.19
15.27%
4.50
27.25%
6.91
53.61%
13.42
94.07%
15.58
16.12%
11.11
28.67%
9.77
12.08%
11.42
16.87%
4.74
58.52%
capex per share
-0.11
-
-0.67
500.95%
-0.11
82.95%
-0.14
23.37%
-0.36
155.82%
-0.97
169.28%
-0.85
12.29%
-1.05
23.78%
-0.47
55.08%
-0.38
19.92%
capex to depreciation
-2.96
-
-7.27
145.92%
-0.92
87.33%
-1.22
32.85%
-2.62
114.25%
-5.25
100.43%
-2.05
60.93%
-3.05
48.79%
-1.01
66.86%
-0.74
27.28%
-1.71
132.82%
capex to operating cash flow
0.06
-
0.21
257.65%
0.03
84.51%
0.03
13.62%
0.09
227.40%
0.17
81.04%
0.14
17.01%
-0.76
656.75%
0.09
111.35%
0.09
9.09%
0.15
60.34%
capex to revenue
-0.27
-
-2.75
935.56%
-3.86
40.30%
-1.27
67.16%
-0.14
89.16%
-0.21
55.75%
-0.16
22.96%
-0.15
7.58%
-0.05
63.97%
-0.03
39.76%
-0.06
85.28%
cash per share
7.59
-
5.26
30.77%
4.55
13.39%
6.53
43.40%
18.35
181.07%
17.72
3.41%
15.28
13.77%
24.87
62.76%
26.04
4.71%
24.48
5.98%
days of inventory on hand
29.31
-
35.97K
-
4.15K
88.46%
1.34K
67.73%
1.11K
17.45%
1.34K
20.84%
700.34
47.57%
531.82
24.06%
783.83
47.39%
days payables outstanding
71.29
-
83.36K
-
420.30
99.50%
361.11
14.08%
439.23
21.63%
639.74
45.65%
288.62
54.88%
249.98
13.39%
400.38
60.17%
days sales outstanding
90.61
-
90.38
0.26%
1.16K
1,181.81%
352.01
69.62%
69.58
80.23%
59.47
14.54%
90.03
51.40%
93.65
4.02%
89.26
4.70%
101.59
13.82%
117.52
15.68%
debt to assets
0.01
-
0.02
274.92%
0.09
298.45%
0.04
55.44%
0.33
765.43%
0.34
2.49%
0.40
18.50%
0.42
6.00%
0.45
5.57%
0.52
15.42%
0.43
17.24%
debt to equity
0.01
-
0.03
278.67%
0.12
381.07%
0.05
60.98%
0.55
1,038.65%
0.54
1.62%
0.89
65.97%
1.66
86.43%
1.52
8.60%
4.20
176.51%
1.63
61.31%
dividend yield
earnings yield
-0.16
-
-0.23
44.36%
-0.13
42.48%
-0.20
48.37%
-0.02
92.26%
-0.05
223.20%
-0.08
50.38%
-0.04
44.61%
-0.06
37.26%
-0.07
16.74%
enterprise value
434.23M
-
511.95M
17.90%
1.57B
207.58%
1.23B
21.92%
3.10B
152.46%
7.28B
134.52%
9.39B
29.04%
12.86B
36.91%
6.34B
50.70%
11.18B
76.34%
968.38M
91.34%
enterprise value over ebitda
-6.36
-
-3.91
38.57%
-7.15
83.01%
-4.61
35.55%
-13.00
182.07%
-21.24
63.34%
-20.01
5.78%
-24.30
21.43%
-15.38
36.69%
-23.61
53.47%
-3.62
84.69%
ev to operating cash flow
-6.71
-
-3.98
40.66%
-10.54
164.51%
-5.00
52.53%
-13.38
167.51%
-18.73
39.99%
-20.58
9.88%
119.67
681.52%
-14.31
111.95%
-34.36
140.21%
-1.93
94.38%
ev to sales
30.54
-
52.47
71.82%
1.26K
2,295.06%
226.80
81.95%
20.08
91.15%
24.18
20.43%
24.67
2.00%
23.81
3.46%
9.03
62.07%
11.98
32.66%
0.78
93.50%
free cash flow per share
-2.02
-
-3.88
91.90%
-3.65
6.00%
-5.19
42.22%
-4.30
17.04%
-6.84
58.83%
-7.05
3.14%
0.32
104.60%
-5.93
1,928.95%
-4.38
26.05%
free cash flow yield
-0.10
-
-0.27
170.14%
-0.09
64.75%
-0.19
100.03%
-0.08
59.10%
-0.06
19.02%
-0.05
12.77%
0.00
103.48%
-0.07
3,562.72%
-0.03
48.61%
graham net net
6.47
-
4.53
29.86%
2.97
34.57%
4.94
66.63%
10.61
114.66%
10.02
5.61%
3.75
62.54%
-0.83
122.04%
1.45
275.19%
-5.63
488.39%
graham number
23.31
-
21.73
6.79%
22.95
5.62%
29.22
27.29%
16.13
44.80%
43.76
171.32%
49.29
12.62%
39.53
19.79%
36.39
7.95%
30.38
16.52%
income quality
0.58
-
0.95
63.85%
0.68
28.24%
0.92
35.40%
4.58
397.62%
1.07
76.54%
0.64
40.56%
-0.19
130.38%
1.06
645.66%
0.46
56.30%
0.93
102.11%
intangibles to total assets
0.02
-
0.02
15.47%
0.02
21.50%
0.02
21.51%
0.01
42.37%
0.01
35.78%
0.01
2.73%
0.00
33.40%
0.00
0.94%
0.00
46.45%
0
100%
interest coverage
-276.94
-
498.56
-
-29.69
105.96%
-10.19
65.67%
-17.03
67.07%
-9.41
44.74%
-7.08
24.78%
-10.07
42.24%
interest debt per share
0.06
-
0.16
168.38%
0.55
249.96%
0.32
42.04%
7.43
2,216.14%
8.88
19.58%
10.33
16.29%
17.01
64.74%
18.13
6.58%
20.56
13.37%
inventory turnover
12.45
-
0.01
-
0.09
766.84%
0.27
209.92%
0.33
21.13%
0.27
17.24%
0.52
90.74%
0.69
31.69%
0.47
32.15%
invested capital
0.01
-
0.03
278.67%
0.12
381.07%
0.05
60.98%
0.55
1,038.65%
0.54
1.62%
0.89
65.97%
1.66
86.43%
1.52
8.60%
4.20
176.51%
1.63
61.31%
market cap
689.52M
-
579.18M
16.00%
1.63B
181.70%
1.34B
18.13%
3.27B
145.00%
7.23B
120.92%
9.50B
31.39%
13.29B
39.91%
7.32B
44.94%
10.53B
43.90%
net current asset value
226.43M
-
200.42M
11.49%
141.11M
29.59%
286.06M
102.73%
709.90M
148.16%
816.38M
15.00%
464.28M
43.13%
262.24M
43.52%
384.13M
46.48%
-185.56M
148.30%
174.09M
193.82%
net debt to ebitda
3.74
-
0.51
86.28%
0.26
49.63%
0.40
54.16%
0.71
77.30%
-0.15
120.54%
0.22
254.86%
0.81
261.45%
2.37
192.09%
-1.37
157.92%
-3.62
163.18%
net income per share
-3.31
-
-3.39
2.55%
-5.20
53.36%
-5.49
5.49%
-0.86
84.30%
-5.46
533.91%
-9.71
77.81%
-7.11
26.82%
-5.15
27.50%
-8.66
67.99%
operating cash flow per share
-1.91
-
-3.21
68.03%
-3.53
10.05%
-5.05
42.83%
-3.94
21.86%
-5.87
48.74%
-6.20
5.70%
1.38
122.23%
-5.45
495.61%
-4.00
26.59%
payables turnover
5.12
-
0.00
-
0.87
19,733.61%
1.01
16.39%
0.83
17.78%
0.57
31.34%
1.26
121.65%
1.46
15.46%
0.91
37.57%
receivables turnover
4.03
-
4.04
0.26%
0.32
92.20%
1.04
229.12%
5.25
405.91%
6.14
17.01%
4.05
33.95%
3.90
3.87%
4.09
4.93%
3.59
12.15%
3.11
13.55%
research and ddevelopement to revenue
5.13
-
9.66
88.35%
116.83
1,109.75%
34.73
70.27%
1.08
96.89%
1.33
23.78%
1.47
10.34%
1.34
9.19%
1.10
17.85%
0.94
14.44%
0.71
24.93%
return on tangible assets
-0.39
-
-0.47
20.16%
-0.82
75.38%
-0.64
22.00%
-0.04
93.90%
-0.22
466.48%
-0.39
77.95%
-0.19
52.78%
-0.13
28.35%
-0.23
68.68%
-0.16
27.17%
revenue per share
0.42
-
0.24
41.97%
0.03
87.85%
0.11
275.72%
2.63
2,260.90%
4.54
72.89%
5.17
13.85%
6.93
33.92%
8.64
24.67%
11.48
32.93%
roe
-0.45
-
-0.55
21.03%
-1.16
110.82%
-0.79
31.33%
-0.06
91.91%
-0.35
445.89%
-0.87
149.28%
-0.73
16.77%
-0.45
37.96%
-1.83
304.97%
-0.62
65.87%
roic
-0.43
-
-0.52
21.27%
-1.01
93.30%
-0.73
26.97%
-0.15
80.04%
-0.22
47.41%
-0.33
51.73%
-0.27
18.25%
-0.19
29.53%
-0.26
39.45%
-0.11
56.61%
sales general and administrative to revenue
2.22
-
5.05
127.47%
59.89
1,084.94%
14.98
74.99%
0.78
94.82%
0.70
10.03%
0.75
7.21%
0.59
21.30%
0.40
31.58%
0.48
20.14%
shareholders equity per share
7.30
-
6.19
15.27%
4.50
27.25%
6.91
53.61%
13.42
94.07%
15.58
16.12%
11.11
28.67%
9.77
12.08%
11.42
16.87%
4.74
58.52%
stock based compensation to revenue
0.78
-
2.09
166.46%
25.63
1,129.26%
5.53
78.44%
0.20
96.43%
0.17
15.51%
0.21
23.95%
0.20
3.05%
0.16
18.87%
0.25
53.84%
0.15
41.22%
tangible asset value
242.15M
-
241.76M
0.16%
183.71M
24.01%
328.62M
78.88%
774.86M
135.80%
1.02B
31.73%
805.69M
21.07%
748.13M
7.14%
913.77M
22.14%
377.37M
58.70%
859.34M
127.72%
tangible book value per share
7.15
-
6.04
15.57%
4.34
28.08%
6.75
55.35%
13.17
95.22%
15.41
16.95%
10.94
28.96%
9.60
12.31%
11.24
17.17%
4.64
58.70%
working capital
234.84M
-
210.93M
10.18%
162.25M
23.08%
298.05M
83.70%
1.14B
282.59%
1.25B
9.84%
1.20B
3.86%
2.07B
71.84%
2.15B
3.97%
1.94B
9.91%
1.93B
0.65%

All numbers in USD (except ratios and percentages)